can you take semaglutide and then switch to tirzepatide Maintenance therapy on or TrimRX | Semaglutide vs Tirzepatide:

Safety and efficacy of oral semaglutide vs dulaglutide in Japanese T2D patients: the PIONEER 10 trial

The approval represented a significant milestone as Wegovy became the first FDA-approved treatment for chronic weight management in adults since 2014, strengthening the adoption of long-acting GLP-1 analogues in obesity care In August 2021, results from the STEP 1 clinical trial of once-weekly semaglutide 2.4 mg were published in the New England Journal of Medicine, showing substantial weight reduction in adults with overweight or obesity without diabetes

6 The likelihood of taking inappropriate medication increases with the number of drugs prescribed

Huang X, Wu M, Lin J, Mou L, Zhang Y, Jiang J